We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Rober Showcases Pressure Ulcer Protection for Critically Ill Patients

By HospiMedica International staff writers
Posted on 31 Jan 2017
Image: The pressure ulcer mattress for critically ill patients (Photo courtesy of Rober Limited).
Image: The pressure ulcer mattress for critically ill patients (Photo courtesy of Rober Limited).
UK-based pressure ulcer specialist, Rober Limited showcased its state-of-the-art pressure ulcer mattress at Arab Health 2017 that has been developed specifically for patients who are critically ill or in intensive care. At the four-day event held from January 30 to February 2, 2017, in Dubai, United Arab Emirates, Rober also launched NoDec WIZARD, an innovative mattress that prevents pressure injuries from developing in immobile patients. The dynamic system, which mechanically replicates the body’s natural spontaneous movement, also features clinically proven therapeutic technology that promotes the healing of established ulcers.

The WIZARD is part of Rober’s new pressure ulcer mattress range, which focuses on four key areas – microclimate control, patient safety and comfort, maximizing infection control and offering additional nursing support. The NoDec WIZARD has a three-cell cycle that moves up and down in a wave-like motion, providing regular and complete pressure elimination to all parts of the body in contact with the mattress.

The mattress also features a tilt function that laterally rotates the patient from left or right on either a continuous or a programmed 6-hour basis. The slow and controlled tilt transfers the body support laterally, thus changing contact points as well as assisting with pulmonary functions and reducing the requirement for manual handling. The NoDec WIZARD is fully automatic and anyone nursed upon it requires less manual repositioning. Other additional features include a touchscreen visual display panel, comfort settings, timed static mode, audible and visual alarms and permanently inflated side formers.

Mike Hutson, Chief Executive of Robert, said, “We are very excited to be showcasing the NoDec Wizard at Arab Health 2017. It is part of our new generation of mattresses and has been designed to offer maximum flexibility to critically ill patients who are at risk of pressure damage. It is an effective and proven solution in the prevention and treatment of pressure ulcers and will transform care across the Middle East.”

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
Knee Arthroscopy Holder
Reison 10-353 XL
New
Radial Artery Compression Device
TR Band

Channels

Surgical Techniques

view channel
Image: For the first time, a fluorescent-guided nerve imaging agent has shown promise for use in humans (Photo courtesy of VUMC)

Fluorescent Imaging Agent ‘Lights Up’ Nerves for Better Visualization During Surgery

Surgical nerve injury is a significant concern in head and neck surgeries, where nerves are at risk of being inadvertently damaged during procedures. Such injuries can lead to complications that may impact... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more